This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
EMERYVILLE, Calif., Feb. 19, 2013 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leading renewable chemicals and fuels company, today announced financial results for the fourth quarter and year ended December 31, 2012.
In the final quarter of 2012, we completed commissioning and began commercial production of our industrial-scale farnesene production plant in Brazil. Also, we secured additional capital from some of our largest shareholders," said
John Melo, President & CEO of Amyris. "
Amyris is focused on continued execution of our business strategy with the goal of achieving positive cash flow in 2014, underpinned by a reduced operating expense profile, strong product and collaboration revenues, and ongoing support from our investors," Melo concluded.
FINANCIAL RESULTSQuarter Ended December 31, 2012
Aggregate revenues for the quarter ended December 31, 2012 were $5.9 million versus $41.5 million in the fourth quarter of 2011. The decline in revenue was due to the Company's planned transition out of the ethanol and ethanol-blended gasoline business, which was completed in the third quarter of 2012. Of the $5.9 million in aggregate revenues during the quarter ended December 31, 2012, $3.0 million related to renewable product sales compared to $0.7 million for the same period in the prior year.
Total research & development and sales, general & administrative expenses declined 20.3% to $35.5 million from $44.5 million in the same quarter of the prior year, primarily due to reductions in personnel related costs and overall lower spending.
GAAP net loss attributable to common stockholders for the quarter was $43.5 million ($0.72 per share) compared to a loss of $59.4 million ($1.30 per share) in the same quarter of 2011. On a non-GAAP basis, excluding stock-based compensation of $6.1 million and a loss on firm commitments related to contract manufacturing operations of $7.8 million, the net loss attributable to common stockholders was $29.7 million ($0.49 per share) compared to $52.8 million ($1.15 per share) in the prior year. A reconciliation of GAAP to non-GAAP results is included in this release.